Evidence map›Paper›PMID 28975505›Full record

ReviewJournal of neurovirology2018

An SIV/macaque model targeted to study HIV-associated neurocognitive disorders.

Sarah E Beck, Suzanne E Queen, Kelly A Metcalf Pate, Lisa M Mangus, Celina M Abreu, Lucio Gama, Kenneth W Witwer, Robert J Adams, M Christine Zink, Janice E Clements and 1 more

Abstract readReview
In one paragraph

Review in Journal of neurovirology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Switch from Glial to Neuronal Gene Expression Alterations in the Spinal Cord of SIV-infected Macaques on Antiretroviral Therapy.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Sarah E BeckDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Suzanne E QueenDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Kelly A Metcalf PateDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Lisa M MangusDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Celina M AbreuDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Lucio GamaDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Kenneth W WitwerDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Robert J AdamsDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
M Christine ZinkDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Janice E ClementsDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Joseph L MankowskiDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA. jmankows@jhmi.edu.ORCID 0000-0002-6283-4727
Johns Hopkins University · US

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Project 4: Intracellular mechanism of virus persistence in astrocytes/macrophagesP01MH070306 · NIMH · JOHNS HOPKINS UNIVERSITY · PI CLEMENTS, JANICE E · 2004 to 2015
$16.0M
Viral Testing CoreU42OD013117 · OD · JOHNS HOPKINS UNIVERSITY · PI Lydia Hopper, JOSEPH L MANKOWSKI · 2017 to 2026
$10.9M
Project !: Differential contribution of resting CD4+ T cells and resident macrophages to viral rebound after antiretroviral treatment interruptionP01AI131306 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MAC GABHANN, FEILIM C · 2017 to 2021
$8.5M
Training Veterinarians for Careers in Biomedical ResearchT32OD011089 · OD · JOHNS HOPKINS UNIVERSITY · PI JOSEPH L MANKOWSKI · 2012 to 2026
$6.7M
Development of an SPF Macaca nemestrina Breeding ColonyP40OD013117 · OD · JOHNS HOPKINS UNIVERSITY · PI ADAMS, ROBERT J. · 2012 to 2016
$4.9M
Macrophage Ontogeny and Polarization in HIV/SIV InfectionR01AI127142 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CLEMENTS, JANICE E, GAMA, LUCIO · 2016 to 2020
$3.8M
Novel SIV Model of HANDR01NS077869 · NINDS · JOHNS HOPKINS UNIVERSITY · PI CLEMENTS, JANICE E, MANKOWSKI, JOSEPH L · 2012 to 2016
$3.8M
Eradicating Latent SIV from the CNS by CCR5 InhibitionR01NS089482 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MANKOWSKI, JOSEPH L · 2014 to 2018
$3.8M
Mechanisms of HIV-Induced PNS Disease: The SIV Macaque ModelR01NS055651 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MANKOWSKI, JOSEPH L · 2006 to 2009
$2.5M
Macrophage Polarization in SIV Infection and LatencyR56AI118753 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CLEMENTS, JANICE E · 2015 to 2015
$773k
The Role of Platelet-Monocyte Interactions in SIV InfectionK01OD018244 · OD · JOHNS HOPKINS UNIVERSITY · PI PATE, KELLY ANN METCALF · 2014 to 2018
$657k
NIAID NIH HHS P01 AI131306NIAID NIH HHS P30 AI094189NIAID NIH HHS P30AI094189NIAID NIH HHS R01 AI127142NIAID NIH HHS R01AI127142NIAID NIH HHS R56 AI118753NIAID NIH HHS R56AI118753NIH HHS K01 OD018244NIH HHS K01OD018244NIH HHS K01 OD021323NIH HHS K01OD021323NIH HHS P40OD0131117NIH HHS P40 OD013117NIH HHS T32 OD011089NIH HHS T32OD011089NIH HHS U42 OD013117NIMH NIH HHS P01 MH070306NIMH NIH HHS PO1MH070306NINDS NIH HHS NS055651NINDS NIH HHS NS077869NINDS NIH HHS NS089482NINDS NIH HHS R01 NS055651NINDS NIH HHS R01 NS077869NINDS NIH HHS R01 NS089482
6 · The paper itself

Abstract

Simian immunodeficiency virus (SIV) infection of pigtailed macaques is a highly representative and well-characterized animal model for HIV neuropathogenesis studies that provides an excellent opportunity to study and develop prognostic markers of HIV-associated neurocognitive disorders (HAND) for HIV-infected individuals. SIV studies can be performed in a controlled setting that enhances reproducibility and offers high-translational value. Similar to observations in HIV-infected patients receiving antiretroviral therapy (ART), ongoing neurodegeneration and inflammation are present in SIV-infected pigtailed macaques treated with suppressive ART. By developing quantitative viral outgrowth assays that measure both CD4+ T cells and macrophages harboring replication competent SIV as well as a highly sensitive mouse-based viral outgrowth assay, we have positioned the SIV/pigtailed macaque model to advance our understanding of latent cellular reservoirs, including potential CNS reservoirs, to promote HIV cure. In addition to contributing to our understanding of the pathogenesis of HAND, the SIV/pigtailed macaque model also provides an excellent opportunity to test innovative approaches to eliminate the latent HIV reservoir in the brain.

Indexed as

Disease Models, AnimalAIDS Dementia ComplexAnimalsAntiretroviral Therapy, Highly ActiveAntiviral AgentsCentral Nervous SystemCognitive DysfunctionHumansMacaca nemestrinaMacrophagesSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusT-LymphocytesViral LoadVirus LatencyAntiviral AgentsAnti-retroviral therapyHANDHIVLatent CNS reservoirsMacaqueMacrophageQVOASIV

Identifiers

PMID28975505
PMCPMC5882604
OpenAlexW2763075550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.